At the same time, it is found that MET gene amplification is independently related to CD8+T cell infiltration level, and the infiltration rate of CD8+T cells in NSCLC is as high as 68.9%, which indicates that MET may become a potential target for immunotherapy of NSCLC [27]. Here, MET is linked to non-small cell lung carcinoma.